Like many of its peers, Tilray is struggling after its fiscal 2019 third-quarter release. Though its revenue met estimates, its stock continues to slide.
On October 28, Cronos (CRON) closed at 11.39 Canadian dollars on the Toronto Stock Exchange. This implies a 3.96% decline since the beginning of October.
So far, cannabis stocks have struggled this year. Many of the stocks didn’t impress investors with their earnings results. Analysts downgraded and cut many...
In recent news, Tilray Inc. (TLRY) exported medical marijuana to Switzerland. The company exported medical marijuana extracts to cater to the needs of patients...
